2026-01-10 - Analysis Report
Okay, here's a breakdown of the Lam Research (LRCX) stock information, combining the data provided with analysis.  All dates are assumed to be correct as of the original provided data.

**1. Performance vs. S&P 500 (VOO)**

*   **Company Overview:** Lam Research Corp. designs, manufactures, markets, and services semiconductor processing equipment used in the fabrication of integrated circuits.
*   **LRCX Cumulative Return:** 274.10%
*   **VOO Cumulative Return:** 92.74%
*   **Divergence:** 153.5 (Relative Divergence: 100.0)

**Analysis:**

*   LRCX has significantly outperformed the S&P 500.  The cumulative return difference is substantial (153.5 percentage points).
*   The Relative Divergence of 100.0 indicates that the current divergence is at the highest point in the observed historical range. This suggests a significant outperformance recently, but also potentially signals an overbought condition.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B)  |
|------------|--------|--------|--------|-------|---------|
| 2016-2018  | 1.0%   | 34.2%  | -2.0%  | 1.6   | 18.7    |
| 2017-2019  | 38.0%  | 34.2%  | 21.0%  | 1.7   | 40.1    |
| 2018-2020  | 57.0%  | 34.2%  | 36.0%  | 1.5   | 64.7    |
| 2019-2021  | 105.0% | 24.5%  | 62.0%  | 1.6   | 98.5    |
| 2020-2022  | -11.0% | 49.0%  | -9.0%  | 1.6   | 57.6    |
| 2021-2023  | -14.0% | 49.0%  | -15.0% | 1.8   | 107.3   |
| 2022-2024  | -47.0% | 42.4%  | -66.0% | 1.9   | 99.0    |
| 2023-2025  | 150.0% | 43.7%  | 88.0% | 2.0   | 234.6   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Shows significant volatility.  High growth periods (e.g., 2019-2021, 2023-2025) alternate with periods of negative growth (2020-2022, 2021-2023, 2022-2024).  The recent 2023-2025 CAGR is extremely strong.
*   **MDD (Maximum Drawdown):** Reflects the potential downside risk. Drawdowns are substantial, indicating that the stock is sensitive to market corrections and economic downturns.
*   **Alpha:**  Indicates performance relative to the benchmark (S&P 500).  Positive alpha periods (especially 2019-2021, 2018-2020, and 2023-2025) demonstrate outperformance. Negative alpha periods (2016-2018, 2020-2022, 2021-2023, 2022-2024) show underperformance.  The most recent Alpha is very strong.
*   **Beta:**  Measures volatility relative to the market.  Beta values consistently above 1 (ranging from 1.5 to 2.0) indicate that LRCX is more volatile than the S&P 500. The Beta is trending higher, implying increasing sensitivity to market movements.
*   **Cap(B) (Capitalization in Billions):** General growth in the company's capitalization, with a massive recent increase.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 200.96
*   **Last Market Data:**  Price: 218.36, Previous Close: 200.96, Change: 8.66
*   **5-day SMA:** 198.164
*   **20-day SMA:** 176.7235
*   **60-day SMA:** 161.118

**Analysis:**

*   The stock price shows a strong upward trend (218.36), significantly above all moving averages.
*   The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA, confirming the bullish trend.
*   The substantial price increase from the previous close (change of 8.66) and the large gap between the current price and the moving averages suggest strong momentum.

**3. Market Risk Indicators**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment Recommended)
*   **RSI:** 81.95 (Overbought)
*   **PPO:** 1.52
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2026-01-05)
*   **Recent (20 days) relative divergence change:** 0.0 (-): 단기하락 (Short-term decline)
*   **Expected Return (%):** 11.0

**Analysis:**

*   The MRI suggests a medium investment recommendation.
*   The RSI of 81.95 indicates the stock is overbought, suggesting a potential pullback or consolidation.
*   The PPO (Percentage Price Oscillator) indicates the relationship between two moving averages, which appears to reflect a recent price increase (positive).
*   Hybrid Signal Suggests to buy.
*   The 20-day relative divergence change indicating a short-term decline is concerning given the context of the current high price.
*   The expected return of 11% is positive, suggesting that, despite short-term risk, long-term prospects remain favorable.

**4. Recent News & Significant Events**

*   **Positive Headlines:** Multiple news articles highlight the stock's recent surge (e.g., "Why Is Lam Research (LRCX) Stock Soaring Today," "$LRCX stock is up 8% today"), with some pointing to underlying data supporting the increase. Articles also suggest a "Buy" due to growth.
*   **Analyst Upgrade:** Mizuho raised its price target to $220, signaling confidence in the stock's future performance.
*   **Risk Acknowledgment:** Forbes article warns about the risks.
*   **Overall Sentiment:** The news is overwhelmingly positive, reflecting the stock's recent strong performance.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.77)
*   **Opinions:** 30
*   **Target Price (avg/high/low):** 175.30 / 260.00 / 115.00
*   **Recent Rating Changes:**  No specific information provided on recent rating changes.

**Analysis:**

*   The analyst consensus is a "Buy" with a significant number of opinions.
*   The average target price is much lower than the current market price, indicating that analysts are pricing in a correction or mean reversion to the upside. A high of $260 indicates some optimistic expectations.
*   The lack of information on recent rating changes makes it difficult to determine if analyst sentiment is shifting.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-10-24 | 1.24 | 5.32 B$  |
| 2025-04-25 | 1.04 | 4.72 B$  |
| 2025-01-31 | 0.93 | 4.38 B$  |
| 2024-10-28 | 0.86 | 4.17 B$  |
| 2025-10-24 | 0.86 | 4.17 B$  |

**Analysis:**

*   Both EPS (Earnings Per Share) and Revenue show a clear upward trend. The last recorded EPS (1.24) is the highest in the provided data, and revenue (5.32 B$) is also at the peak. This indicates strong financial performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $5.32B  | 50.43%        |
| 2025-06-30   | $5.17B  | 50.08%        |
| 2025-03-31   | $4.72B  | 49.02%        |
| 2024-12-31   | $4.38B  | 47.37%        |
| 2024-09-30   | $4.17B  | 48.05%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-09-30   | $10.19B  | 15.39%   |
| 2025-06-30   | $9.86B   | 17.44%   |
| 2025-03-31   | $9.51B   | 13.99%   |
| 2024-12-31   | $8.81B   | 13.52%   |
| 2024-09-30   | $8.47B   | 13.18%   |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue is consistently growing, and the Profit Margin is also expanding. This indicates improved operational efficiency.
*   **Equity & ROE (Return on Equity):**  Equity is increasing, demonstrating the company's growing net worth.  ROE is volatile from period to period, indicating the volatility of the capital's productivity.

**7. Comprehensive Analysis**

*   **Strong Recent Performance:** Lam Research has significantly outperformed the S&P 500, especially recently.
*   **High Volatility:** The stock is more volatile than the market (Beta > 1), and the Maximum Drawdown figures are substantial.
*   **Overbought Condition:** RSI indicates the stock is overbought, increasing the risk of a short-term correction.
*   **Strong Fundamentals:** Revenue, EPS, and Profit Margin are all showing strong upward trends, suggesting solid financial health.
*   **Positive Sentiment:** News headlines and analyst consensus are generally positive.
*   **Valuation Concerns:** The current market price is much higher than analysts' average target price, suggesting a potential overvaluation.
*   **Semiconductor Industry Exposure:** Lam Research is highly dependent on the semiconductor industry cycle. The cyclical nature of the industry exposes the stock to the swings in demand.

**Overall Recommendation:**

Based on the analysis, LRCX presents a mixed picture:

*   **Positive:** Strong recent performance, excellent growth in revenue and earnings, positive analyst sentiment, and high expected return.
*   **Negative:** High volatility, overbought condition, possible overvaluation, and cyclical industry exposure.

Given the overbought condition and the large divergence from analysts' target prices, caution is warranted in the short term.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.